In summary, our data suggest that HDAC2 expression is increased in physiologically normal smokers but reduced in current smokers with COPD, though the latter finding is partly confounded by general decrease in cellularity in the LP. Here, HDAC2 is linked to chronic obstructive pulmonary disease.